After completing the required training for office-based opioid treatment, what must a provider do before treating patients?

The requirement to wait up to 45 days to receive a waiver after completing the necessary training for office-based opioid treatment is based on regulatory standards in the field of addiction treatment. Following the completion of the training, a provider must apply for a waiver from the Substance Abuse and Mental Health Services Administration (SAMHSA) to be authorized to prescribe medications for opioid use disorder (OUD). This process involves submitting an application that is then reviewed, which is why there can be a waiting period.

The waiting period allows for proper verification of qualifications and preparedness for prescribing medication-assisted treatment (MAT). This is crucial as it ensures that providers are equipped with the necessary knowledge and skills to treat patients safely and effectively, following established protocols.

In contrast, beginning treatment immediately after the course lacks this essential verification step, which could potentially compromise patient safety. Applying for an extended waiver implies an incorrect understanding of the current regulations, as this is not a necessary step for providers aiming to treat OUD. Lastly, treating all patients off-label does not comply with established practices and regulations surrounding the treatment of opioid dependence; treatments must be done within the context of approved guidelines.